Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Dyne Therapeutics Inc (NASDAQ: DYN) was $13.67 for the day, down -0.36% from the previous closing price of $13.72. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 13.08 million shares were traded. DYN stock price reached its highest trading level at $14.2075 during the session, while it also had its lowest trading level at $13.4.
Ratios:
Our analysis of DYN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.02 and its Current Ratio is at 17.02. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on December 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $46.
On November 26, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $45.
JP Morgan Downgraded its Overweight to Neutral on October 24, 2024, whereas the target price for the stock was revised from $43 to $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 11 ’24 when Beskrovnaya Oxana sold 2,334 shares for $28.12 per share. The transaction valued at 65,632 led to the insider holds 201,685 shares of the business.
Scalzo Richard William sold 1,455 shares of DYN for $40,915 on Dec 11 ’24. The SVP, Head of Finance & Admin. now owns 127,078 shares after completing the transaction at $28.12 per share. On Dec 11 ’24, another insider, HIGH SUSANNA GATTI, who serves as the Officer of the company, bought 5,270 shares for $28.33 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 1391141248 and an Enterprise Value of 697412928.
Stock Price History:
The Beta on a monthly basis for DYN is 1.06, which has changed by -0.35221905 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $13.44. The 50-Day Moving Average of the stock is -44.04%, while the 200-Day Moving Average is calculated to be -57.02%.
Shares Statistics:
DYN traded an average of 1.38M shares per day over the past three months and 3398840 shares per day over the past ten days. A total of 101.75M shares are outstanding, with a floating share count of 77.75M. Insiders hold about 23.60% of the company’s shares, while institutions hold 86.77% stake in the company. Shares short for DYN as of 1735603200 were 10515884 with a Short Ratio of 7.63, compared to 1732838400 on 10352296. Therefore, it implies a Short% of Shares Outstanding of 10515884 and a Short% of Float of 12.2700006.
